Salugan, Nina H.
HRN: 26-48-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
CIPROFLOXACIN 500MG (TAB)
07/22/2026
07/28/2026
ORAL
500MG
BID
DECUBITUS ULCER
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes